Abstract
On June 30, 2015, the U.S. Food and Drug Administration implemented the Pregnancy and Lactation Labeling Rule (PLLR). The PLLR was issued to address the shortcomings of pregnancy and lactation information in prescription drug and biological product labeling. The new labeling format under PLLR is structured to better help providers communicate important information about the risks and benefits of taking a specific medication to their pregnant or breastfeeding patients.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
